NCT04163419 2024-03-13
Phase 2 Study of Tanezumab in Subjects With Moderate to Severe Pain Due to Schwannomatosis
Massachusetts General Hospital
Phase 2 Unknown
Massachusetts General Hospital
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Peking Union Medical College Hospital
National Cancer Centre, Singapore